Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis.

John O MascarenhasMaria R BaerCraig KesslerElizabeth HexnerDouglas TremblayLeah PriceLonette SandyRona WeinbergHeike PahlLewis R SilvermanJudith D GoldbergHeidi KosiorekAmylou C DueckRonald Hoffman

Published in: Leukemia & lymphoma (2019)

Keyphrases

open label
placebo controlled
clinical trial
study protocol